{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:04:39Z","timestamp":1790813079253,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["404610\/2021-8"],"award-info":[{"award-number":["404610\/2021-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.prp.2024.155680","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T01:43:22Z","timestamp":1730079802000},"page":"155680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["BCL-2 and \u03b3-H2AX immunostaining profile in urothelial bladder cancer prognosis"],"prefix":"10.1016","volume":"264","author":[{"given":"Julia Ayumi Ikeda","family":"Kawasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais Capelasso Lucas","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabely Mayara","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Miqueloto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Braj\u00e3o","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Lu\u00eds","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda Fiorina Maria Losi","family":"Guembarovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Terziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilner","family":"Martinez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Mara","family":"Serpeloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Losi","family":"Guembarovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155680_bib1","unstructured":"Global Cancer Observatory, Estimated number of new cases from 2020 to 2025, incidence, both sex, age, [0-+85], Bladder. \u3008https:\/\/gco.iarc.fr\/tomorrow\/en\/dataviz\/tables?years=2025&single_unit=5000&cancers=30&group_cancers=0&multiple_cancers=0&sexes=0&populations=903_904_905_908_909_935_900\u3009; 2024 (accessed 05 May 2024)."},{"key":"10.1016\/j.prp.2024.155680_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","article-title":"Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Powles","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2024.155680_bib3","first-page":"466","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"46","author":"Sylvester","year":"2006","journal-title":"EAU"},{"key":"10.1016\/j.prp.2024.155680_bib4","first-page":"549","article-title":"The impact of bladder cancer on health-related quality of life","volume":"121","author":"Smith","year":"2018","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.prp.2024.155680_bib5","first-page":"4701","article-title":"Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes","volume":"53","author":"Krajewski","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2024.155680_bib6","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1073\/pnas.94.10.5113","article-title":"Channel formation by antiapoptotic protein BCL-2","volume":"94","author":"Schendel","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2024.155680_bib7","doi-asserted-by":"crossref","first-page":"18361","DOI":"10.1074\/jbc.M100655200","article-title":"Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane","volume":"276","author":"Mikhailov","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2024.155680_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/21681805.2019.1575467","article-title":"Is BCL-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?","volume":"53","author":"Turker","year":"2019","journal-title":"Scand. J. Urol."},{"key":"10.1016\/j.prp.2024.155680_bib9","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"Double-stranded breaks induce histone H2AX phosphorylation on serine 139*","volume":"273","author":"Rogakou","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2024.155680_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ncb3445","article-title":"A hypoxia-responsive TRAF6-ATM-H2AX signaling axis promotes HIF1\u03b1 activation, tumorigenesis and metastasis","volume":"19","author":"Rezaeian","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.prp.2024.155680_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/597095","article-title":"DNA damage sensor \u03b3-H2AX is increased in preneoplastic lesions of hepatocellular carcinoma","volume":"2013","author":"Matsuda","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.prp.2024.155680_bib12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.juro.2008.10.146","article-title":"Phosphorylated H2AX in noninvasive low grade urothelial carcinoma of the bladder: correlation with tumor recurrence","volume":"181","author":"Cheung","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2024.155680_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2217\/bmm.15.2","article-title":"Poor prognosis of constitutive \u03b3-H2AX expressing triple-negative breast cancers is associated with telomere length","volume":"9","author":"Nagelkerke","year":"2015","journal-title":"Biomark. Med"},{"key":"10.1016\/j.prp.2024.155680_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.molcel.2007.12.029","article-title":"Bcl2 negatively regulates DNA double-strand break repair through a non-homologous end joining pathway","volume":"29","author":"Wang","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.prp.2024.155680_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2024.155680_bib16","article-title":"AJCC Cancer Staging Manual","volume":"8","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin. Ed."},{"key":"10.1016\/j.prp.2024.155680_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00432-022-04274-w","article-title":"Tissue immunostaining of candidate prognostic proteins in metastatic and non-metastatic prostate cancer","volume":"149","author":"Pereira","year":"2023","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155680_bib18","first-page":"1","article-title":"Allelic variants and immunostaining prolife in CXCL12\/CXCR4 axis: an investigation of association with prognosis in prostate cancer","volume":"250","author":"Francelino","year":"2023","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2024.155680_bib19","first-page":"1","article-title":"Metalloproteinase 9 immunostaining prolife is positively correlated with tumor grade, extraprostatic extension and biochemical recurrence in prostate cancer","volume":"235","author":"Pinheiro","year":"2024","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2024.155680_bib20","first-page":"1","article-title":"Presence, subtypes, and prognostic significance of tertiary lymphoid structures in urothelial carcinoma of the bladder","volume":"29","author":"Ma","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.prp.2024.155680_bib21","first-page":"1","article-title":"Association of age with non-muscle-invasive bladder cancer: unearthing a biological basis for epidemiological disparities?","volume":"31","author":"Lobo","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2024.155680_bib22","first-page":"1","article-title":"The value of BCL-2 and CK20 expression in predicting behavioral patterns of bladder cancer, a cross sectional study","volume":"81","author":"Pourebrahimi","year":"2022","journal-title":"Ann. Surg."},{"key":"10.1016\/j.prp.2024.155680_bib23","first-page":"1","article-title":"Tobacco carcinogens and the methionine metabolism in human bladder cancer","volume":"178","author":"Wojtczyk-miaskowska","year":"2019","journal-title":"Mutat. Res."},{"key":"10.1016\/j.prp.2024.155680_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-023-11460-7","article-title":"Prevalence and characteristics of patients with upper urinary tract urothelial carcinoma having potential Lynch syndrome identified by immunohistochemical universal screening and Amsterdam criteria II","volume":"23","author":"Tanabe","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2024.155680_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-023-11299-y","article-title":"PDL1 protein expression by combined positive score (CPS) in patients with muscle invasive or advanced urothelial carcinoma a single institution experience","volume":"23","author":"Nasr","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2024.155680_bib26","first-page":"343","article-title":"Effect of conjugated linoleic acid (CLA) supplementation on expression of B-Cell Lymphoma-2 (BCL-2) in the bladder epithelium of Wistar (Rattus norvegicus) rats exposed to cigarette smoke","volume":"75","author":"Daryanto","year":"2022","journal-title":"Arch. Med Res."},{"key":"10.1016\/j.prp.2024.155680_bib27","unstructured":"The Human Protein Atlas, BCL2 pathology- Urothelial cancer. \u3008https:\/\/www.proteinatlas.org\/ENSG00000171791-BCL2\/pathology\/urothelial+cancer#ihc\u3009, 2023 (accessed 25 October 2023)."},{"key":"10.1016\/j.prp.2024.155680_bib28","unstructured":"The Human Protein Atlas, BCL2 tissue- Urinary bladder tissue. \u3008https:\/\/www.proteinatlas.org\/ENSG00000171791-BCL2\/tissue\/urinary+bladder\u3009; 2023 (accessed 25 October 2023)."},{"key":"10.1016\/j.prp.2024.155680_bib29","unstructured":"The Human Protein Atlas, H2AX pathology- Bladder tissue. \u3008https:\/\/www.proteinatlas.org\/ENSG00000188486-H2AX\/pathology\/urothelial+cancer\u3009; 2023 (accessed 25 October 2023)."},{"key":"10.1016\/j.prp.2024.155680_bib30","unstructured":"The Human Protein Atlas, H2AX tissue- Urinary bladder tissue. \u3008https:\/\/www.proteinatlas.org\/ENSG00000188486-H2AX\/tissue\/urinary+bladder\u3009; 2023 (accessed 25 October 2023)."},{"key":"10.1016\/j.prp.2024.155680_bib31","first-page":"1238","article-title":"Correlation of mitotic indices AgNor count, ki-67, bcl-2 with grade and stage in papillary urothelial bladder cancer","volume":"11","author":"Goyal","year":"2014","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.prp.2024.155680_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3233\/CBM-160604","article-title":"MGMT hypermethylation and BCL-2 overexpression associated with superficial bladder cancer and recurrence","volume":"16","author":"Jahed","year":"2016","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.prp.2024.155680_bib33","first-page":"229","article-title":"A immunohistochemical expression of BCL-2 and EGFR biomarkers in urothelial carcinoma of the bladder lesions and its relation to grade: Immunohistochemical expression of BCL-2 and EGFR biomarkers in urothelial carcinoma","volume":"59","author":"Mostafaee","year":"2021","journal-title":"Ethiop. Med J."},{"key":"10.1016\/j.prp.2024.155680_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.prp.2013.04.006","article-title":"Beclin 1 and bc-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters","volume":"209","author":"Baspinar","year":"2013","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2024.155680_bib35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00204-020-02950-9","article-title":"Expression of stem cell markers as useful complementary factors in the early detection of urinary bladder carcinogens by immunohistochemistry for \u03b3-H2AX","volume":"95","author":"Yamada","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.prp.2024.155680_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1293\/tox.2020-0038","article-title":"Role of \u03b3-H2AX as a biomarker for detection of bladder carcinogens in F344 rats","volume":"33","author":"Suzuki","year":"2020","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.prp.2024.155680_bib37","first-page":"1","article-title":"gamma-H2AX: a potential biomarker in breast cancer","volume":"41","author":"Varvara","year":"2019","journal-title":"Tumor Bio"},{"key":"10.1016\/j.prp.2024.155680_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9092844","article-title":"H2A histone family member x (H2AX) is upregulated in ovarian cancer and demonstrates utility as a prognostic biomarker in terms of overall survival","volume":"9","author":"Saravi","year":"2020","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.prp.2024.155680_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/01913123.2011.620221","article-title":"Prognostic value of bcl-2 and bax tumor cell expression in patients with non muscle-invasive bladder cancer receiving bacillus calmette-guerin immunotherapy","volume":"36","author":"Ajili","year":"2012","journal-title":"Ultra Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824005910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824005910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:29:31Z","timestamp":1778747371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824005910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"alternative-id":["S0344033824005910"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155680","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCL-2 and \u03b3-H2AX immunostaining profile in urothelial bladder cancer prognosis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155680"}}